Mehul Patel, MD, PharmD

The Rapid Mood Screener: A Novel and Pragmatic Screener Tool for Bipolar I Disorder

Introduction: Depressive episodes/symptoms of bipolar I disorder (BPD-I) are commonly misdiagnosed as major depressive disorder (MDD). We developed the novel and pragmatic Rapid Mood Scre...

Patrick Gillard , PharmD, MS;

Amanda Harrington , PhD;

Kate Sullivan , APN, RN;

Lauren Nelson , PhD;

Roger McIntyre , MD, FRCPC;

Susan McElroy , MD;

Rakesh Jain , MD, MPH, RD;

Charles Brendan Montano , MD;

Mehul Patel , MD, PharmD;

T. Michelle Brown , PhD;

Prakash M. Masand , MD;

10/08/2020

Depressive Symptoms – Could it be Bipolar Depression? An Overview for Primary Care

Depression is often the initial and predominant disease presentation in patients with bipolar disorder leading to their frequent misdiagnosis with major depressive disorder. Primary care ...

Charles Brendan Montano , MD;

Donna Rolin , PhD, APRN, PMHNP-BC;

Mehul Patel , MD, PharmD;

Andrea Wilson , PharmD, BCPS, PhD;

10/08/2020

Efficacy of Cariprazine in Patient Subgroups: Post Hoc Analysis of 3 Randomized, Placebo-Controlled Trials in Patients With Bipolar Depression

Introduction: Cariprazine is a dopamine D3-preferring D3/D2 and serotonin 5-HT1A receptor partial agonist approved to treat bipolar depression. The efficacy of cariprazine in patients wit...

Vladimir Maletic , MD;

Lakshmi Yatham , MBBS, FRCPC, MRCP, MBA;

Rakesh Jain , MD, MPH, RD;

Willie Earley , MD;

Mehul Patel , MD, PharmD;

Mauricio Tohen , MD, DrPH, MBA;

10/08/2020

Bipolar Disorder Treatment Patterns in the United States: A Retrospective Claims Database Study

Background: The objective of this retrospective study was to describe treatment patterns among patients with bipolar disorder.

Mehul Patel , MD, PharmD;

Patrick Gillard , PharmD, MS;

Amanda Harrington , PhD;

Amanda Kong , DrPH;

Rakesh Jain , MD, MPH, RD;

10/08/2020

Efficacy (NNT) and Tolerability (NNH) of Cariprazine in Bipolar Disorder

Background: Cariprazine is approved to treat manic, mixed, and depressive symptoms of bipolar I disorder. This analysis describes the efficacy and tolerability of cariprazine in bipolar I...

Willie Earley , MD;

Mehul Patel , MD, PharmD;

Mauricio Tohen , MD, DrPH, MBA;

Leslie Citrome , MD;

11/22/2019

Effects of Cariprazine on Prolactin Levels in Patients With Bipolar I Disorder

Background: Antipsychotic treatment has been linked to hyperprolactinemia, which can lead to increased nonadherence and changes in sexual hormones in both men and women. Here, we evaluate...

Mehul Patel , MD, PharmD;

Larry Culpepper , MD;

Deanna Kelly ;

Eduard Vieta , MD, PhD;

Thais Moreira , PharmD, PhD;

Willie Earley , MD;

11/22/2019

Cariprazine for Bipolar I Depression: A Randomized Double-Blind Placebo-Controlled Trial

Depressive episodes in bipolar I disorder (BP-1) are associated with increased disability, morbidity, and suicide, and have fewer evidence-based treatment options compared to manic episod...

Trisha Suppes , MD, PhD;

Mauricio Tohen , MD, DrPH, MBA;

Joseph Calabrese , MD;

Willie Earley , MD;

Maria Burgess , MD;

Barbara Khan , MS;

Ludmyla Rekeda , PhD;

Mehul Patel , MD, PharmD;

03/01/2019